Holen Sie sich die Stockscreener-App
2.39
2.14%
0.05
Schlusskurs vom Vortag:
$2.34
Offen:
$2.38
24-Stunden-Volumen:
34,491
Relative Volume:
0.67
Marktkapitalisierung:
$3.75M
Einnahmen:
$574.20K
Nettoeinkommen (Verlust:
$-11.52M
KGV:
-0.0521
EPS:
-45.8332
Netto-Cashflow:
$-6.92M
1W Leistung:
+8.64%
1M Leistung:
+10.65%
6M Leistung:
-56.62%
1J Leistung:
+565.74%
1-Tages-Spanne:
$2.2601
$2.49
1-Wochen-Bereich:
$2.20
$2.49
52-Wochen-Spanne:
$0.312
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Firmenname
Aethlon Medical Inc
Sektor
Branche
Telefon
619-941-0360
Adresse
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
2.39 | 3.67M | 574.20K | -11.52M | -6.92M | -45.83 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Fortgesetzt | H.C. Wainwright | Neutral |
Aethlon Medical Inc Aktie (AEMD) Neueste Nachrichten
Advancements in Novel Immunotherapeutics in The Oncology Battle - ADVFN
Fundamentals Check: Will Aethlon Medical Inc stock recover after earningsTrade Analysis Summary & High Yield Stock Recommendations - baoquankhu1.vn
US Market Wrap: Is Aethlon Medical Inc a strong growth stock2026 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
What is the fair value of Aethlon Medical Inc. stock now2026 Sector Review & Technical Pattern Based Signals - Bollywood Helpline
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Aethlon Medical Update: DSMB Clears Aussie Oncology Trial to Advance Hemopurifier to Cohort 3 - Defense World
Death Cross: How is Aethlon Medical Inc managing supply chain issues2026 Analyst Calls & Risk Controlled Daily Trade Plans - baoquankhu1.vn
Aethlon Medical (AEMD) director forfeits 178 shares to cover RSU taxes - Stock Titan
Aethlon Medical (NASDAQ: AEMD) director forfeits 178 shares for tax withholding - Stock Titan
Director at Aethlon (NASDAQ: AEMD) forfeits shares to cover taxes - Stock Titan
Aethlon Medical : Corporate OverviewMarch 2026 - marketscreener.com
Performance Recap: Whats the profit margin of Aethlon Medical IncQuarterly Profit Report & High Accuracy Investment Entry Signals - baoquankhu1.vn
Aethlon Medical advances to final cohort in cancer device trial By Investing.com - Investing.com Australia
Market Pulse: How is Aethlon Medical Inc managing supply chain issuesWeekly Trend Report & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Bitget
AEMD Technical Analysis & Stock Price Forecast - Intellectia AI
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2026 earnings call transcript - MSN
Cancer device study moves forward after reviewers find no safety issues - Stock Titan
Novel Immunotherapeutics Stocks in the News (Nasdaq:AEMD), (Nasdaq:HURA) (NYSE: AZN) (Nasdaq: ELTX) - Investorideas.com
AEMD Trial Progress: Aethlon Medical Advances to Final Cohort - GuruFocus
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review - Investorideas.com
Aethlon Medical advances to final cohort in cancer device trial - Investing.com
Aug Closing: Does Aethlon Medical Inc offer margin of safetyWatch List & Fast Moving Stock Watchlists - baoquankhu1.vn
If You Invested $1,000 in Aethlon Medical (AEMD) - Stock Titan
Aethlon Medical, Inc.: Fundamental Analysis and Financial Ratings | EJU0 | US00808Y5050 - marketscreener.com
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR - Yahoo Finance
Aethlon Medical announces full exercise of pre-funded warrants By Investing.com - Investing.com India
Aethlon Medical announces full exercise of pre-funded warrants - Investing.com
Aethlon Medical, Inc. Announces All Pre-Funded Warrants Exercised; 1,569,110 Shares Outstanding as of March 16, 2026 - Minichart
Aethlon Medical Completes Pre-Funded Warrant Exercises, Simplifying Equity - TipRanks
All Aethlon Medical (AEMD) pre-funded warrants exercised, 1,569,110 shares out - Stock Titan
Aethlon Medical hires Maxim Group to explore strategic options - Investing.com Nigeria
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) on the Move – Morning High of $2.09 - Investorideas.com
Aethlon Medical hires Maxim Group to explore strategic options By Investing.com - Investing.com South Africa
Aethlon Medical at Life Sciences Forum: Hemopurifier’s Oncology Focus By Investing.com - Investing.com Canada
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Gains on News - Investorideas.com
Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: AEMD) Engages Maxim Group LLC to Evaluate Strategic Opportunities - Investorideas.com
Aethlon Medical (AEMD) Explores Strategic Opportunities with Max - GuruFocus
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Cancer and infection treatment developer Aethlon explores deals with Maxim - Stock Titan
Aethlon Medical Q1 2026 Earnings Preview - MSN
Winners Losers: Is Aethlon Medical Inc showing insider buyingIPO Watch & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Investment Review: Whats the profit margin of Aethlon Medical IncPortfolio Value Report & Verified Short-Term Plans - baoquankhu1.vn
Aethlon Medical to Present at Life Sciences Investor Forum - Intellectia AI
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th - GlobeNewswire
Energy Moves: Can Aethlon Medical Inc continue delivering strong returnsInsider Buying & Safe Capital Growth Trade Ideas - baoquankhu1.vn
AEMD SEC FilingsAethlon Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions - Benzinga
Aethlon Medical to Present at Emerging Growth Conference - Intellectia AI
Ask Aethlon Medical’s CEO and CFO live at Emerging Growth Conference - Stock Titan
Zacks Research Weighs in on Aethlon Medical FY2026 Earnings - Defense World
Finanzdaten der Aethlon Medical Inc-Aktie (AEMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):